Exfoliative dermatitis - Exfoliativ Dermatitis
☆ AI Dermatology — Free Service
An den 2022 Stiftung Warentest Resultater aus Däitschland war d'Zefriddenheet vum Konsument mam ModelDerm nëmme liicht manner wéi mat bezuelte Telemedizin Konsultatiounen.
An den 2022 Stiftung Warentest Resultater aus Däitschland war d'Zefriddenheet vum Konsument mam ModelDerm nëmme liicht manner wéi mat bezuelte Telemedizin Konsultatiounen.
Rout (brennend) Hautsyndrom ― Erythema a Skala um ganze Kierper sinn d'Haaptsymptomer vun Exfoliativ Dermatitis (Exfoliative dermatitis).
relevance score : -100.0%
ReferencesErythroderma ass e rare awer schwéier Hautkonditioun. Wärend déi exakt Ursaach dacks onbekannt ass, kann et duerch eng Drogenreaktioun oder en ënnerierdesche Kriibs ausgeléist ginn. Ee gemeinsame Kriibs verbonne mat exfoliativer Dermatitis ass cutan T‑cell-Lymphom, wat vläicht keng Symptomer fir Méint oder souguer Joeren no der Hautkonditioun ufänkt. Normalerweis ass d'Spidolisation néideg fir eng initial Bewäertung a Behandlung. Patienten mat Drogen-induzéierter Krankheet hunn allgemeng e gudde laangfristeg Ausbléck, obwuel Fäll ouni kloer Ursaach e widderhuelend a remittéierend Kurs hunn. D'Prognose fir Fäll verbonne mat Kriibs hänkt normalerweis dovun of wéi de Kriibs weidergeet.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Et weist typesch verbreet Roudheet an Schuppen iwwer 90 % vum Kierper. Dësen Zoustand ass e sichtbare Zeeche vu verschiddenen ënnerierdesche Gesondheetsproblemer wéi Psoriasis, Ekzeme oder eng Reaktioun op bestëmmte Medikamenter.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Déi heefegst Ursaach vun Erythroderma ass d'Vergréisserung vun enger ënnerierdeger Hautkrankheet, wéi Psoriasis, Kontaktdermatitis, seborrheescher Dermatitis, Lichen planus, Pityriasis rubra pilaris oder eng Drogenreaktioun, sou wéi d'Benotzung vun topesch Steroiden. Primär Manifestatioun ass manner heefeg a gëtt normalerweis a Fäll vu kutanes T‑Zell‑Lymphom gesi. Well et wichteg ass, vum kutanes T‑Zell‑Lymphom ze differenzéieren, gëtt eng Biopsie gemaach.